NATUREXA World Leader in specialty plant-based natural ingredients

April 2011

� NATUREX at a glance

� A world leader in specialty plant-based natural ingredients

� A unique expertise in the manufacturingof specialty plant-based natural ingredients

� Three strategic and complementary markets

� A worldwide sales network

� Well positioned on fast growing end-markets

� New challenges in “natural” and “health” perception

� Customized solutions’ Provider for diversified and international customers

� Main players by product range

� The keys for a continuous growth

� A growth story

� The consolidation of the market is a growth driver

� High barriers to entry: A sustainable and profitable competitive advantage

� Strategy and outlook: Driving profitable growth

� A growth and ISR value

� Sustainability and Corporate Responsibility

� Capital and shareholders

� Financial Communications Agenda and Upcoming events

� Appendices

2

Agenda

NATUREX at a glance

3

� World leader in specialty plant-based natural ingredients for Food & Beverage, Nutrition & Health and Personal Care markets

� Created in 1992Head Office in Avignon (France)

� Listed on the Stock Market since 1996 NYSE EURONEXT Paris Compartment B

Stock market capitalisation: €324 million(As at April 18th, 2011)

� Worldwide geographical presencevia a dedicated sales network in 19 countries

� High sourcing capacityall over the World

� High performance industrial resources through 11 industrial sites

� Strong Research & Development

� Preferred customer relations with over 2,000 customers

� A wide product range with over 1,500 listed products

� 950 employees worldwideof which 15% working with the Scientific Department

4

A world leader in specialty plant-based natural ingredients

5

A unique expertise in the manufacturing of specialty plant-based natural ingredients

Sourcing

Selection of premium botanicals

Production

Huge capabilities and technologies

Quality Control

Tight monitoring for traceability

InnovationCreation of added-value ingredients

Naturex controls all the stages of the

manufacturing process

6

Three strategic and complementary markets

Nutrition & Health Personal Care

NAT stabil® NAT arom®

NAT color® NAT healthy™

F&V powders Pectins

NAT life™ NAT activ®

NAT pharma™

NAT beauty™ NAT select™

NAT protect™

Food & Beverage

Plant extractsSubstitute to

chemical antioxydants

Flavoring extractsThrough a rich palette

of oleoresins and essential oils

Natural colorsColor solutions

with natural pigments

Botanical extracts With beneficial effects on health (antioxidant,

stress, digestive health…)

Powders from fruits and

vegetables

Apple and Citrus pectins for

Confectionary, Jam…

Branded ingredient concepts

Registered trademarks

Innovative plant extracts (cognitive performance,

anti stress, weight management,menopause…)

Botanical extracts

With beneficial effects on health

Plant extracts With Active Substance / Master Files (ASMFS)

Branded active ingredients

Registered trademarksWith In Vitro researchInnovative solutions

(anti-aging from Peruvian Maca, slimming active

from decaffeinated green coffee…)

Botanical extracts

For cosmetic applications

Natural ExtractsWith preservative

properties (antioxidants,

antimicrobials)

Natural flavoring, coloring,

preservative and healthy ingredients

Botanical extracts and

branded ingredients concepts

Natural ingredients concepts,

botanical extracts and

functional raw materials

7

New Jersey

Milan

Avignon

A worldwide sales network

Singapore

Shanghai

Tokyo

Birmingham

Brussels

Köln

Sao Paulo

Sydney

Valencia

Dubai

Moscow

Bischofszell

Bangkok

Ontario

Seoul

Mexico

8

Well positioned on fast growing end-markets

9

New challenges in « natural » and « health » perception

Natural and Health

claims create value

Source: World Nutraceutical

Ingredients study Freedonia

Group – November 2009

Personal Care

Natural personal care products

2004-2009 / Worldwide

+15%

Natural cosmetics products

2010 / Europe €2.0bn

+12%

Source: Kline Group – March 2010

Organic Monitor – Oct. 2009

Source: NBJ 2010

Euromonitor 2009

Food & Beverage

Natural and organic foods

2012 / Worldwide

+10%

F&B with health claim

2007-2012 / Worldwide

+22%

$179bn

F&B Bio

2007-2012 / Worldwide

+34%

$30.5bn

Nutrients and minerals

2010-2013 / Worldwide

Nutraceuticalingredients

2010-2013 / Worldwide

$12.6bn

$21.8bn

+6.4%

+6.2%

Nutrition & Health

10

� Strong customer’s relationship with « best-of-class” players of Food&Beverage, Nutrition,

Pharmaceutical and Cosmetics Industries

Customized solutions’ Provider for diversified and international customers

Pharmaceutical, nutritional

supplement, dietary… companies

Cosmetics, Personal Care & Beauty brands

Multinational companies in Food &

Beverage

11

Food & BeverageNutrition &

Health

Na

tura

l

co

lors

Fla

vo

rin

g

ex

tra

cts

An

tio

xid

an

t

Ro

se

ma

ry

ex

tra

ct

Fru

it a

nd

Ve

ge

tab

le

po

wd

ers

Fru

it p

ec

tin

s

Ex

tra

cts

wit

h

be

ne

fic

ial

eff

ec

ts o

n

he

alt

h

Chris Hansen (Denmark) �

CPKelco (USA) �

Cargill (USA) �

Danisco (Denmark) � �

D.D Williamson (USA) �

Diana Naturals (France) �

Euromed (Spain) �

Finzelberg-Plantextrakt (Germany) �

Frutarom (Israel) �

GNT (Germany) �

Indena (Italy) �

Kalsec (USA) � �

Kerry (Ireland) �

Sensient (USA) �

Vitiva (Slovenia) �

Main playersby product range

12

The keys for a continuous growth

13

A growth storyNet sales x20 in 10 years

12.216.1

29.6 28.134.8

50.1

66.2

79.5

93.2101.9

186.1

226.3

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2009 PF 2010

Sale

s i

n €

m

Solid fundamentals

� Strong organic growth

� A track-record of 8 successful acquisitions in 8 years

Substantial upside to expect

� Major synergies and cross-selling

� Numerous strategic geographical build up opportunities

2009 PF sales include sales generated by the Ingredients Division of Natraceutical Group which were consolidated as of January 1, 2010

January 2007HAMMER PHARMA€8m

14

January 2002BRUCIA€8m

April 2004HAUSER RFI€3m

July 2005PURE WORLD€31m

The consolidation of the market is a growth driver

April 2007HP BOTANICALS€3m

� A spectacular know-how of acquisition and integration

December 2007CHART CORPORATION€8m

January 2008BERKEM ACTIFS INNOVANTS€4m

December 2009NATRACEUTICAL INGREDIENTS DIVISION€85m

� Skills in supplying unique natural raw materials, strong purchasing power to secure prices and quantities

� Technological know-howManufacturing sites, advanced extraction capabilities and sales networks worldwide

� Tailor-made solutions through innovative specialty plant-based natural ingredients

� Coverage of a wide customer needs range through our big size and large product portfolio

� Constant review of EFSA (European Food Safety Authority)

for products with “health” or “natural” claims

� Ability to handle EDMF (European Drug Master File)

for pharmaceuticalcompounds

CRITICAL SIZE

PREFERRED PARTNER

15

High barriers to entry: A sustainable and profitable competitive advantage

REGULATIONS

INNOVATION

� Strong R&D and high level of Quality Control15% of employees working in Science Department

� Several patents and publications in peer-reviewed

scientific journals

� Go on with strong organic growth and rise in operating margin

� Optimize the synergies and cross-selling opportunities through our different locations

� Increase market focus innovation through R&D and quality certifications

� Consider new opportunities of acquisitions to complete our range of products and reinforce our geographical positions

16

Strategy and OutlookDriving profitable growth

17

A growth and ISR value

� Social Responsibility

� Member of the United Nations Global CompactCommitted to the principles of human rights, labour, environment and anti-corruption

� Member of SedexTo share with our suppliers ethical data and to improve ethical performance of our supply chains

� Environmental sustainabilityFor sustainable sourcing, manufacturing and offerings

� Quality, safety and environment certifications

� ISO 9001, ISO 14001

� OHSAS 18001

� Food BRC

� USDA Organic

� cGMP (NSF)

� API (Active Pharmaceuticals Ingredients)

� Bio european label

� All manufacturing sites are Kosher and Halal approved

Sustainability and Corporate Responsibility

18

Sustainability and Corporate Responsibility

� Community involvementTo manage the impacts of our business on communities and to fit their lifestyles

� NATUREX FoundationCreated in March 2008

� Dedicated to improving life conditionsin communities from which Naturex derives plantmaterials

� Supports in particular education, medicine, environmentand basic necessities, outside of any economic interest

19

20

Equity story of a premium company

� Number of shares: 6,410,931NYSE Euronext Paris – B Compartment

since October 1996

� 4,959,935 ordinary shares (FR0000054694)

� 1,450,996 preference shares (FR0000010833251)

� Market capitalisation: €324.0m(As at April 18th, 2011)

� Fiscal year: from 1st January to 31 December

� General Meeting: June

� Contract of liquidity: NATIXIS

� Last dividend distribution: September 2010€0.11/share – Payment option in shares followed at 85.6%

� Analysts: ID Midcaps, KEPKER Capital Markets,

NATIXIS, PORTZAMPARC, RB Milestone

�Evolution over the last 12 months: +63.80%

�Evolution over the last 6 months: +21.00%

REUTERS: NATU.PA ; BLOOMBERG: NRX:FP

Index: CAC Small, Gaïa Index

Eligible for DSS “long-only”

Share price evolutionJanuary 2010-April 2011

21

A well-balanced shareholders’ structure

Capital6,410,931 shares

Voting Rights5,037,250 rights

� Sharehoders’ agreement between SGD / J. DIKANSKY and NATRA Group

Action in concert

SGD / J. DIKANSKY

and

NATRA Group

Source: SGSS/GIS – March 31, 2011

SGD / J. DIKANSKY

16.22%

NATRA Group36.11%

Public47.52%

Auto-Detention0.15%

Public62.20%

NATRA Group17.15%

SGD / J. DIKANSKY

20.65%

22

Financial Communications Agenda

FY 2011

1st quarter results 30 may 2011

1st half-year sales 26 july 2011

1st half year results 31 august 2011

3rd quarter sales 4 november 2011

3rd quarter results 30 november 2011

Annual sales 24 january 2012

Annual results 30 march 2012

Release after the close of market

23

Upcoming Events

2011

NYSE EURONEXT Food & Beverage

Conference

19 May 2011

Annual General Meeting 27 june 2011

SFAF meeting (half-year results)

Paris

16 september 2011

Midcap Event

Paris

22-23 september 2011

Actionaria

Paris

18-19 november 2011

Thank you for your attention

24

Thierry LambertVice-President and CFO

E-mail : t.lambert@naturex.com

Tel. : :+ 33 (0)4 90 23 96 89

Carole AlexandreInvestor Relations

E-mail : c.alexandre@naturex.com

Tel. : :+ 33 (0)4 90 23 78 28

Contacts

www.naturex.com

25

Appendices

26

Growth in all markets andall geographic zones

2010 vs 2009 PF

� Revenues per market � Revenues per geographic zone

F&B N&H Personal Care

Misc. Total

137.1 75.5 2.7 11.0 226.3

+22.7% +13.7% +68.8% +71.9% +21.6%

Vente

s en M€

2010 vs 2009 PF

Europe/Africa

Americas Asia/Pacific

Total

117.7 84.1 24.5 226.3

+28.2% +15.5% +14.0% +21.6%V

ente

s en M€

60.6%

33.4%

1.2% 4.8%

Food & Beverage Nutrition & health Personal Care Miscellaneous

52.0%

37.2%

10.8%

Europe / Africa Americas Asia / Pacific

27

Net profit multiplied by nearly 3 compared with 2009

In € millionsIFRS

2010 2009 Pro forma

2009

Revenues 226.3 186.1 101.9

Gross margin 132.1 103.2 68.5

gross margin % 58.4% 55.5% 67.2%

Operating income 27.3 16.8 13.1

operating margin % 12.1% 9.0% 12.8%

Net cost of financial debt (5.6) (5.3) (4.1)

Other income and financial charges (0.7) (0.2) (0.5)

Net pre-tax profit 21.1 11.3 8.4

Tax expense (6.2) (3.3) (1.9)

Income from companies, equity method - (1.2) (1.2)

Net profit, Group share 14.8 6.8 5.2

Net profitability % 6.5% 3.7% 5.1%

Average exchange rate for dollar ($) 1.3220 1.3876 1.3876

2009 PF accounts include the Ingredients Division of the Natraceutical Group, consolidated as from January 1st, 2010

28

A sound balance sheet

In € mIFRSASSETS

31/12/10 31/12/09

Non-current assets 189.4 164.0

Goodwill 83.9 74.1

Intangible assets 6.3 3.0

Tangible assets 92.3 83.7

Financial assets 0.7 1.4

Deferred tax assets 5.7 1.8

Derived instruments non current assets 0.5 -

Current assets 168.7 133.3

Inventory 98.2 76.8

Payable tax assets 3.1 1.5

Customers and other debtors 49.6 39.4

Derived instruments current assets 0.3 -

Cash and cash equivalent 17.5 15.6

Non-current assets held for sale - 0.8

TOTAL ASSETS 358.1 298.1

In € mIFRSLIABILITIES

31/12/10 31/12/09

Shareholder equity 168.8 144.8

Non-current liabilities 124.3 91.9

Non-current financial debts 108.4 82.8

Non-current provisions 2.2 1.5

Deferred taxes 11.2 7.6

Derived instruments non-current liabilities 2.5 -

Current liabilities 65.0 61.4

Current provisions 0,6 2.8

Payable tax liabilities 1.3 0.4

Suppliers and other creditors 51.2 36.7

Other financial liabilities 9.9 16.3

Derived instruments current liabilities 0.7 -

Bank advances 1.3 5.2

TOTAL LIABILITIES 358.1 298.1

29

A tightly controlled financial debt

In € m 31/12/2010 31/12/09

Shareholder capital 168.8 144.8

Net financial debt 102.1 88.8

Gearing(Net debt/shareholder capital)

60.5% 61.3%

� Split of the net financial debt by currency as at 31.12.2010

� A healthy financial structure

39.0%

43.0%

18.0% Euros

Dollars

Swiss Francs

Spain -Valencia

France - Avignon

Italy- Milan

Approved by the Italian Ministry of Health for

the manufacture of Active Pharmaceuticals

Ingredients (API)

USA - California

FDA registered and follows cGMP

recommendations

USA - New JerseycGMP certified (NSF),

Approved by the FDA for the

manufacture of Active

Pharmaceutical Ingredients (API)

Morocco -Casablanca

UK- Birmingham

Switzerland -Bischofszell and Burgdorf

Brazil - Manaus

ISO 9001ISO 14001

OHSAS 18001

Australia - Sydney

All sites are Kosher and Halal approved

Follows HACCP

recommendations

Quality, safety and environment certifications to improve our manufacturing performance

30

www.naturex.com